Insider · CIK 0001177176

VACZY CATHERINE M

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001177176

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-04-21	GNPXGenprex, Inc.P Purchase	EVP GC Chief Strategy Officer	PPurchase	+20K sh	$1.07	+$21.5K	265,000
2023-02-18	GNPXGenprex, Inc.A Award	EVP GC Chief Strategy Officer	AAward	+245K sh	—	—	245,000
2022-02-04	GNPXGenprex, Inc. · Stock Option (right to buy)A Award	EVP GC Chief Strategy Officer	AAward	+325K sh	—	—	325,000
2021-03-19	GNPXGenprex, Inc. · Stock Option (right to buy)A Award	EVP GC Chief Strategy Officer	AAward	+200K sh	—	—	200,000
2015-04-13	LSTALISATA THERAPEUTICS, INC.A Award	General Counsel	AAward	+3,971 sh	—	—	71,234
2015-02-05	LSTALISATA THERAPEUTICS, INC.A Award	General Counsel	AAward	+30K sh	—	—	79,359
2015-02-05	LSTALISATA THERAPEUTICS, INC.F Tax Payment	General Counsel	FTax Payment	−12.1K sh	$3.54	−$42.8K	67,263
2015-01-02	LSTALISATA THERAPEUTICS, INC. · Stock Option (right to purchase)A Award	General Counsel	AAward	+45K sh	—	—	45,000
2014-12-31	LSTALISATA THERAPEUTICS, INC.A Award	General Counsel	AAward	+962 sh	$3.20	+$3,082.729	49,359
2014-08-01	LSTALISATA THERAPEUTICS, INC.A Award	General Counsel	AAward	+11.8K sh	—	—	48,397
2014-08-01	LSTALISATA THERAPEUTICS, INC. · Stock Option (right to purchase)A Award	General Counsel	AAward	+25K sh	—	—	25,000
2014-06-30	LSTALISATA THERAPEUTICS, INC.A Award	General Counsel	AAward	+556 sh	$5.54	+$3,081.352	36,641
2014-01-02	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to purchase)A Award	General Counsel	AAward	+45K sh	—	—	45,000
2013-12-31	LSTALISATA THERAPEUTICS, INC.A Award	General Counsel	AAward	+598 sh	$4.84	+$2,897.31	36,085
2013-07-12	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to purchase)A Award	General Counsel	AAward	+240K sh	—	—	240,000
2013-01-02	LSTALISATA THERAPEUTICS, INC. · Stock Option (right to purchase)A Award	General Counsel	AAward	+250K sh	—	—	250,000
2012-08-16	LSTALISATA THERAPEUTICS, INC.A Award	General Counsel	AAward	+9,500 sh	—	—	354,862
2012-08-16	LSTALISATA THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−9,500 sh	—	—	0
2012-06-25	LSTALISATA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	General Counsel	AAward	+64.6K sh	—	—	64,583
2012-04-26	LSTALISATA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	General Counsel	AAward	+58K sh	—	—	58,025
2012-01-06	LSTALISATA THERAPEUTICS, INC.A Award	General Counsel	AAward	+10.7K sh	$0.52	+$5,547.88	345,362
2012-01-06	LSTALISATA THERAPEUTICS, INC. · Stock Options (Right to Buy)A Award	General Counsel	AAward	+150K sh	—	—	150,000
2012-01-04	LSTALISATA THERAPEUTICS, INC. · Stock Options (Right to Buy)A Award	General Counsel	AAward	+200K sh	—	—	200,000
2011-04-04	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+250K sh	—	—	250,000
2010-07-07	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+350K sh	—	—	350,000
2009-11-04	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+100K sh	—	—	100,000
2009-10-30	LSTALISATA THERAPEUTICS, INC.A Award	General Counsel	AAward	+150K sh	—	—	334,693
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Common Stock Warrants (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−2,000 sh	—	—	0
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Common Stock Warrants (right to buy)A Award	General Counsel	AAward	+2,000 sh	—	—	2,000
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−1,500 sh	—	—	0
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+1,500 sh	—	—	1,500
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−7,500 sh	—	—	0
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+7,500 sh	—	—	7,500
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−2,000 sh	—	—	0
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+2,000 sh	—	—	2,000
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−10K sh	—	—	0
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+10K sh	—	—	10,000
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−5,000 sh	—	—	0
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+5,000 sh	—	—	5,000
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−10K sh	—	—	0
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+10K sh	—	—	10,000
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−15K sh	—	—	0
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+15K sh	—	—	15,000
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−10K sh	—	—	0
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+10K sh	—	—	10,000
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−10K sh	—	—	0
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+10K sh	—	—	10,000
2009-10-30	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+54K sh	—	—	53,955
2009-10-29	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	General Counsel	AAward	+100K sh	—	—	100,000
2009-07-08	LSTALISATA THERAPEUTICS, INC.A Award	General Counsel	AAward	+25K sh	—	—	184,693

Recent filings

Accepted (ET)
Apr 244
VACZY CATHERINE M0001437749-23-010869
SEC(opens sec.gov)
Feb 224
VACZY CATHERINE M0001437749-23-004243
SEC(opens sec.gov)
Feb 84
VACZY CATHERINE M0001437749-22-002752
SEC(opens sec.gov)
Mar 234
VACZY CATHERINE M0001437749-21-006914
SEC(opens sec.gov)
Apr 144
NeoStem, Inc.0001144204-15-022785
SEC(opens sec.gov)
Feb 64
NeoStem, Inc.0001144204-15-006858
SEC(opens sec.gov)
Jan 24
NeoStem, Inc.0001144204-15-000245
SEC(opens sec.gov)
Aug 14
NeoStem, Inc.0001144204-14-046550
SEC(opens sec.gov)
Jul 14
NeoStem, Inc.0001144204-14-040908
SEC(opens sec.gov)
Jan 34
NeoStem, Inc.0001144204-14-000582
SEC(opens sec.gov)
Jul 124
NeoStem, Inc.0001144204-13-039413
SEC(opens sec.gov)
Jan 44
NeoStem, Inc.0001144204-13-000886
SEC(opens sec.gov)
Aug 174
NeoStem, Inc.0001144204-12-046896
SEC(opens sec.gov)
Jun 274
NeoStem, Inc.0001144204-12-036783
SEC(opens sec.gov)
Apr 304
NeoStem, Inc.0001144204-12-025084
SEC(opens sec.gov)

Companies

Address

C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450

NEW YORK, NY, 10170